Sign in
4

Changes in Ownership

Pelthos Therapeutics Inc. Filed Acc 0001753926-25-000643

Options or other derivatives

  • CEO, Pres., CFO, Treas & Secty acquired 53,988 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Francis Knuettel II CEO, Pres., CFO, Treas & Secty 2025-04-11 Grant or award · Stock Option +53,988 430,736 D
Loading xslF345X05/ownership.xml…